Garth Cumberlidge, PhD

Garth Cumberlidge has served as the Company’s President, CEO and member of the Board of Directors since September 2005. Dr. Cumberlidge has over 25 years’ experience in the research products, diagnostics and healthcare industries.

Prior to his joining Mimetogen, he was President & CEO of Qbiogene Inc., where over a period of six years he successfully raised over $50 million in venture funding and grew the company to over $50 million in revenues. Prior to that he held a senior executive position in ICN Pharmaceuticals, as Vice President, Worldwide Marketing & Sales for the ICN Biomedicals portfolio. Prior to that he held senior positions in Sigma Chemicals Company as European Sales & Marketing Manager, based in Munich, Germany, and Worldwide Sales & Marketing Manager based in the United States, with responsibility for the sales and marketing strategy for research immuno-chemicals business.